{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:38:11Z","timestamp":1786653491230,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>Tapentadol, a dual-action opioid, is increasingly used for pain management in acute pancreatitis (AP). Although its common side effects are well-documented, cutaneous reactions are rare. We report a 30-year-old gentleman with AP who developed generalized urticaria following oral tapentadol use. The patient had no prior history of atopy or drug allergies. The rash resolved after discontinuation of tapentadol and administration of a short course of corticosteroids and antihistamines. Cutaneous reactions to tapentadol are extremely rare but should be recognized promptly to ensure timely management and prevent unnecessary investigations.<\/jats:p>","DOI":"10.4103\/ijp.ijp_1081_25","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:03:16Z","timestamp":1777575796000},"page":"276-279","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Tapentadol-induced urticarial rash in a patient with acute pancreatitis"],"prefix":"10.4103","volume":"58","author":[{"given":"Srinu","family":"Deshidi","sequence":"first","affiliation":[{"name":"Department of Gastroenterology, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Hanumanthu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, NRI Institute of Medical Sciences, Vishakhapatnam, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Mahajan","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Indian Naval Hospital Ship (INHS) Asvini, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekanth","family":"Appasani","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Krishna Institute of Medical Sciences, Secunderabad, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"R1-20260501","doi-asserted-by":"crossref","first-page":"782151","DOI":"10.3389\/fmed.2021.782151","article-title":"Pain management in acute pancreatitis: A systematic review and meta-analysis of randomised controlled trials","volume":"8","author":"Cai","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"R2-20260501","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4103\/1658-354X.115319","article-title":"Tapentadol hydrochloride: A novel analgesic","volume":"7","author":"Singh","year":"2013","journal-title":"Saudi J Anaesth"},{"key":"R3-20260501","doi-asserted-by":"crossref","first-page":"412","DOI":"10.4103\/ijp.ijp_382_23","article-title":"Skin popping with tapentadol: New challenges in the ongoing opioid crisis","volume":"55","author":"Yogitha","year":"2023","journal-title":"Indian J Pharmacol"},{"key":"R4-20260501","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1136\/bcr-2023-257721","article-title":"Tapentadol dependence through intravenous injection ('shooting') of crushed tablets associated with cutaneous pseudoallergic reactions","volume":"16","author":"Avula","year":"2023","journal-title":"BMJ Case Rep"},{"key":"R5-20260501","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.pan.2025.04.020","article-title":"International Association of Pancreatology Revised Guidelines on Acute Pancreatitis 2025: Supported and Endorsed by the American Pancreatic Association, European Pancreatic Club, Indian Pancreas Club, and Japan Pancreas Society","volume":"25","year":"2025","journal-title":"Pancreatology"},{"key":"R7-20260501","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.18203\/2349-2902.isj20194443","article-title":"Etiology, clinical profile and outcome of acute pancreatitis in a tertiary care teaching hospital in rural South India: A ten year retrospective study","volume":"6","author":"Ramu","year":"2019","journal-title":"Int Surg J"},{"key":"R8-20260501","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/aam.aam_83_20","article-title":"Clinical profile, etiology, and outcome of acute pancreatitis: Experience at a tertiary care center","volume":"21","author":"Patel","year":"2022","journal-title":"Ann Afr Med"},{"key":"R9-20260501","doi-asserted-by":"crossref","first-page":"419","DOI":"10.14309\/ajg.0000000000002645","article-title":"American College of Gastroenterology Guidelines: Management of Acute Pancreatitis","volume":"119","author":"Tenner","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"R10-20260501","doi-asserted-by":"crossref","first-page":"813","DOI":"10.14309\/ajg.0000000000000224","article-title":"Pentazocine, a kappa-opioid agonist, is better than diclofenac for analgesia in acute pancreatitis: A randomized controlled trial","volume":"114","author":"Mahapatra","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"R11-20260501","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.cgh.2023.10.021","article-title":"Buprenorphine versus diclofenac for pain relief in acute pancreatitis: A double-blinded randomized controlled trial","volume":"22","author":"Saini","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R12-20260501","first-page":"e74307","article-title":"Tapentadol: A comprehensive review of its role in pain management","volume":"16","author":"Zavaleta-Monestel","year":"2024","journal-title":"Cureus"},{"key":"R13-20260501","doi-asserted-by":"crossref","first-page":"e00921","DOI":"10.1002\/prp2.921","article-title":"Tapentadol shows lower intrinsic efficacy at m receptor than morphine and oxycodone","volume":"10","author":"Manandhar","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"R14-20260501","doi-asserted-by":"crossref","first-page":"817","DOI":"10.12659\/AJCR.904695","article-title":"Cardiac arrest following drug abuse with intravenous tapentadol: Case report and literature review","volume":"18","author":"Khaja","year":"2017","journal-title":"Am J Case Rep"},{"key":"R15-20260501","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/0091-6749(84)90447-0","article-title":"Induction of human cutaneous mast cell degranulation by opiates and endogenous opioid peptides: Evidence for opiate and nonopiate receptor participation","volume":"73","author":"Casale","year":"1984","journal-title":"J Allergy Clin Immunol"},{"key":"R16-20260501","doi-asserted-by":"crossref","first-page":"iii29","DOI":"10.1093\/annonc\/mdy047.077","article-title":"To assess the pain control and tolerance to drug induced emesis in oral and neck carcinoma patients undergoing chemoradiation treated for pain relief with tapentadol (TAPAL-ER 50) vs. tramadol plus paracetamol with and without anti-emetic support","volume":"29","author":"Narayanasamy","year":"2018","journal-title":"Ann Oncol"},{"key":"R17-20260501","first-page":"1019","article-title":"Drug-induced urticaria: Causes and clinical courses","volume":"10","author":"Rutnin","year":"2011","journal-title":"J Drugs Dermatol"},{"key":"R18-20260501","doi-asserted-by":"crossref","first-page":"732","DOI":"10.4103\/ijd.ijd_307_22","article-title":"Diagnosis and management of urticaria in Indian settings: Skin Allergy Research Society's Guideline-2022","volume":"67","author":"Godse","year":"2022","journal-title":"Indian J Dermatol"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_1081_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:38:23Z","timestamp":1786649903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_1081_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_1081_25","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-10-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-01","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}